4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-085755
Chief Development Officer sold 20,000 shares at an average $72.42 ($1,448,475)
- Chief Development Officer acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-06-10 | Option exercise 10b5-1 | +20,000 | $21.65 | $433,000 | 25,487 | D |
| Guyer William Chief Development Officer | 2025-06-10 | Sale 10b5-1 | −16,918 | $72.36 | $1,224,261 | 8,569 | D |
| Guyer William Chief Development Officer | 2025-06-10 | Sale 10b5-1 | −3,082 | $72.75 | $224,214 | 5,487 | D |
| Derivatives | |||||||
| Guyer William Chief Development Officer | 2025-06-10 | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 390,000 | D | ||
| Open-market sales · 20,000 sh · avg $72.42 · $1,448,475 | |||||||
Loading xslF345X05/ownership.xml…